Endovascular Management of HCCShareLesson 35Are you publishing any of your findings?with Dr. Juan Gimenez, Dr. Tyler Sandow, Dr. Christopher BeckClinical TrialsHepatocellular Carcinoma (HCC)Immune Checkpoint InhibitorsImmunotherapyInterventional Oncology (IO)Neuroendocrine Tumor (NET)Practice ManagementRadiation SegmentectomyTransarterial Chemoembolization (TACE)Y90 RadioembolizationPreviousWith underlying liver disease, do you have a cutoff for how much volume you want to preserve?NextCan you talk about combination therapies with systemic?